Ordinary Adjustment | Solactive Global Vaccines and Infectious Diseases Index CNTR | Effective Date 11th November 2024
Solactive Global Vaccines and Infectious Diseases Index CNTR:
In the ordinary adjustment, the following composition will be implemented effective open 11th November 2024:
PFIZER INC |
BIONTECH SE |
MODERNA INC |
MERCK & CO. INC. |
NOVAVAX INC |
SANOFI SA |
ASTRAZENECA PLC |
GSK PLC |
VAXCYTE INC |
VIR BIOTECHNOLOGY INC |
DYNAVAX TECHNOLOGIES CORP |
3SBIO INC |
GILEAD SCIENCES INC |
IMMUNITYBIO INC |
ELI LILLY & CO |
JOHNSON & JOHNSON |
ZOETIS INC |
WUXI BIOLOGICS CAYMAN INC |
BRISTOL-MYERS SQUIBB CO |
ABBVIE INC |
REGENERON PHARMACEUTICALS |
MARAVAI LIFESCIENCES HOLDINGS INC |
LIVZON PHARMACEUTICAL GROUP INC |
SK BIOSCIENCE ORD |
SHIONOGI & CO LTD ORD |
ADMA BIOLOGICS INC |
BAVARIAN NORDIC A/S |
CELLDEX THERAPEUTICS INC |
TG THERAPEUTICS INC |
LABCORP HOLDINGS INC |